Your browser doesn't support javascript.
loading
Treatment of Parkinson's disease in Zebrafish model with a berberine derivative capable of crossing blood brain barrier, targeting mitochondria, and convenient for bioimaging experiments.
Wang, Lizhen; Sheng, Wenlong; Tan, Zhaoshun; Ren, Qingyu; Wang, Rongchun; Stoika, Rostyslav; Liu, Xuedong; Liu, Kechun; Shang, Xueliang; Jin, Meng.
Affiliation
  • Wang L; Biology Institute, Qilu University of Technology, Shandong Academy of Sciences, Jinan 250103, Shandong Province, China; Engineering Research Center of Zebrafish Models for Human Diseases and Drug Screening of Shandong Province, Jinan 250103, Shandong Province, China.
  • Sheng W; Biology Institute, Qilu University of Technology, Shandong Academy of Sciences, Jinan 250103, Shandong Province, China; Engineering Research Center of Zebrafish Models for Human Diseases and Drug Screening of Shandong Province, Jinan 250103, Shandong Province, China.
  • Tan Z; School of Bioengineering, Qilu University of Technology, Shandong Academy of Sciences, 3501 Daxue Road, Jinan 250353, Shandong Province, China.
  • Ren Q; School of Psychology and mental health, North China University of Science and Technology, 21 Bohai Road, Tang'shan 063210, Hebei Province, China.
  • Wang R; Biology Institute, Qilu University of Technology, Shandong Academy of Sciences, Jinan 250103, Shandong Province, China; Engineering Research Center of Zebrafish Models for Human Diseases and Drug Screening of Shandong Province, Jinan 250103, Shandong Province, China.
  • Stoika R; Department of Regulation of Cell Proliferation and Apoptosis, Institute of Cell Biology, National Academy of Sciences of Ukraine, Lviv 79005, Ukraine.
  • Liu X; Department of Chemistry and Biochemistry, University of Colorado at Boulder, Boulder, CO 80303, United States of America.
  • Liu K; Biology Institute, Qilu University of Technology, Shandong Academy of Sciences, Jinan 250103, Shandong Province, China; Engineering Research Center of Zebrafish Models for Human Diseases and Drug Screening of Shandong Province, Jinan 250103, Shandong Province, China.
  • Shang X; School of Psychology and mental health, North China University of Science and Technology, 21 Bohai Road, Tang'shan 063210, Hebei Province, China. Electronic address: shangxuelianghao@126.com.
  • Jin M; Biology Institute, Qilu University of Technology, Shandong Academy of Sciences, Jinan 250103, Shandong Province, China; Engineering Research Center of Zebrafish Models for Human Diseases and Drug Screening of Shandong Province, Jinan 250103, Shandong Province, China. Electronic address: mjin1985@hot
Comp Biochem Physiol C Toxicol Pharmacol ; 249: 109151, 2021 Nov.
Article in En | MEDLINE | ID: mdl-34343700
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Berberine / Brain / Blood-Brain Barrier Type of study: Etiology_studies / Prognostic_studies Limits: Animals / Humans Language: En Journal: Comp Biochem Physiol C Toxicol Pharmacol Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Berberine / Brain / Blood-Brain Barrier Type of study: Etiology_studies / Prognostic_studies Limits: Animals / Humans Language: En Journal: Comp Biochem Physiol C Toxicol Pharmacol Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2021 Document type: Article Affiliation country: Country of publication: